BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Ascentage Pharma Appoints Thomas J. Knapp as Senior Vice President, General Counsel

  Ascentage Pharma announced the appointment of Thomas J. Knapp as Senior Vice President, General Counsel.

  March 18, 2019

   · 

  2 min read
• Drug Development

  Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.

  Innovent Biologics, Inc. announced that the first patient has been successfully dosed in a Phase I clinical trial of anti-cluster of differentiation 47 monoclonal antibody drug candidate in the United States.

  March 18, 2019

   · 

  5 min read
• Shineco, Inc. Establishes Subsidiary to Capture Industrial Cannabis Market Growth

  Shineco, Inc. announced that the Company has established a wholly owned subsidiary, Beijing Tenjove Newhemp Biotechnology Co., Ltd. on March 13, 2019, to capture growth in the industrial cannabis market.

  March 18, 2019

   · 

  3 min read
• FDA

  FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer

  Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC)

  March 18, 2019

   · 

  13 min read